ComplexCon returns to Long Beach Nov. 6 - 7 with hosts J. Balvin and Kristen Noel Crawley, performances by A$AP Rocky and Turnstile, and more shopping and drops.
Secure your spot while tickets last!
The guy in the photo above is not only taking back all your Sundays, he's also keen on potentially receiving some of your money. When former hedge fund manager Martin Shkreli took over the rights to Daraprim as founder of Turing Pharmaceuticals, he conveniently raised the price "overnight" to the all American tune of an "almost 5,500 percent increase" in price. Daraprim is used to treat toxoplasmosis, a parasitic infection that's capable of causing life-threatening complications in infants and for "people with compromised immune systems," such as those with AIDS and even "certain" cancer patients.
“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Shkreli told the New York Times. “It really doesn’t make sense to get any criticism for this.” Shkreli, photographed above in a crisp Brand New t-shirt whilst holding an adorable pet, is clearly perturbed by the fact that people object to the price hike at all.
As for the man himself, he's clearly in possession of a compellingly juxtaposed music collection. In addition to being an obvious Jesse Lacey head, this supposed AIDS pill price hiker is also quite fond of Chamillionaire's discography:
Shortly after the price hike spawned a lot of stories like this one, Shkreli took to television in an attempt to clarify the necessity of the 5,500 percent increase and voice his support of a profit-driven healthcare market: